A 35-year-old multigravida at 30 weeks gestation with chronic hypertension presents with mild vaginal bleeding and mild abdominal pain. Ultrasound shows a small retroplacental clot (8% placental separation) with normal fetal biometry and reassuring fetal heart rate (145 bpm). Maternal vital signs are stable. What is the most appropriate next step in management?

Explanation

## Clinical Context This is a case of **mild placental abruption** at 30 weeks with: - Small retroplacental clot (8% separation — <20%) - Reassuring fetal status (normal FHR, normal biometry) - Stable maternal hemodynamics - Preterm gestation (30 weeks) ## Management Pathway for Mild Abruption ```mermaid flowchart TD A[Placental Abruption <20% Separation]:::outcome --> B{Maternal Stable + FHR Reassuring?}:::decision B -->|Yes| C[Admit for observation]:::action C --> D[Antenatal corticosteroids if <34 weeks]:::action D --> E[Continuous fetal monitoring]:::action E --> F[Weekly ultrasounds]:::action F --> G{Bleeding recurs or FHR abnormal?}:::decision G -->|Yes| H[Deliver immediately]:::urgent G -->|No| I[Continue expectant management to 34 weeks]:::action B -->|No| J[Emergency delivery]:::urgent ``` ## Key Point: **Mild abruption (<20% separation) with reassuring maternal and fetal status warrants expectant management to allow fetal maturation.** Preterm delivery at 30 weeks carries significant neonatal morbidity; if the fetus is stable, delaying delivery to ≥34 weeks improves neonatal outcomes. ## High-Yield Management Criteria for Expectant Management: | Criterion | Required for Expectant Mx | |-----------|---------------------------| | **Placental separation** | <20% | | **Maternal vital signs** | Stable (no shock) | | **Fetal heart rate** | Reassuring (120–160 bpm) | | **Vaginal bleeding** | Mild, not heavy | | **Uterine tenderness** | Absent or mild | | **Gestational age** | Any (but benefits clearer <34 weeks) | ## Clinical Pearl: **Chronic hypertension is a risk factor for abruption**, but does not change management once abruption is diagnosed. The decision to observe or deliver depends on the **severity of abruption and fetal/maternal status**, not the underlying maternal condition. ## Expectant Management Protocol: 1. **Admit to hospital** for continuous monitoring 2. **Antenatal corticosteroids** (betamethasone 12 mg IM × 2 doses, 24 hrs apart) if <34 weeks — reduces neonatal respiratory distress, IVH, and mortality 3. **Continuous fetal monitoring** (CTG) for at least 24 hours, then daily NST 4. **Weekly ultrasounds** to assess placental clot evolution and fetal growth 5. **Deliver at ≥34 weeks** or earlier if: - Recurrent bleeding - Fetal heart rate becomes non-reassuring - Maternal hemodynamics deteriorate - Signs of DIC develop ## Why Expectant Management Works Here: - **Small clot (8%)** = low risk of rapid expansion or massive hemorrhage - **Reassuring FHR** = fetus is well-oxygenated - **Stable mother** = no evidence of concealed hemorrhage or shock - **Preterm gestation** = neonatal benefits of maturation outweigh abruption risk if bleeding remains stable